PATENT CLAIM ANALYSIS

Application Number: 16019670
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "133100"]

Abstract:
This invention generally relates to methods for the treatment of respiratory diseases, such as asthma, utilizing anti-IL-23A antibodies.

Claim (Index 1):
A method for treating severe persistent asthma comprising administering to a patient an anti-IL-23A antibody.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 94.0
- Lexical Diversity: 1.05
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15327144', '13676511', '14676365', '13287208', '15228254']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.705339478387164
- 35 USC 102 Novelty (BERT): 0.527771942924603
- Combined Prediction Score: 0.687582724840908
- Mean Citation Score: 316.014258
- Max Citation Score: 323.12973
- Similarity Product: 217.7026218044328

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test